JPS50157383A - - Google Patents
Info
- Publication number
- JPS50157383A JPS50157383A JP5798574A JP5798574A JPS50157383A JP S50157383 A JPS50157383 A JP S50157383A JP 5798574 A JP5798574 A JP 5798574A JP 5798574 A JP5798574 A JP 5798574A JP S50157383 A JPS50157383 A JP S50157383A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5798574A JPS5744672B2 (US07122547-20061017-C00002.png) | 1974-05-24 | 1974-05-24 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5798574A JPS5744672B2 (US07122547-20061017-C00002.png) | 1974-05-24 | 1974-05-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS50157383A true JPS50157383A (US07122547-20061017-C00002.png) | 1975-12-19 |
| JPS5744672B2 JPS5744672B2 (US07122547-20061017-C00002.png) | 1982-09-22 |
Family
ID=13071293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5798574A Expired JPS5744672B2 (US07122547-20061017-C00002.png) | 1974-05-24 | 1974-05-24 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5744672B2 (US07122547-20061017-C00002.png) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000027819A3 (de) * | 1998-11-10 | 2000-08-17 | Schering Ag | Anthranilsäureamide und deren verwendung als arzneimittel |
| US7572794B2 (en) | 2004-11-03 | 2009-08-11 | Bayer Schering Pharma Ag | Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors |
| US7615565B2 (en) | 2002-07-31 | 2009-11-10 | Bayer Schering Pharma Aktiengesellschaft | VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines |
| US7902229B2 (en) | 2004-11-03 | 2011-03-08 | Bayer Schering Pharma Ag | Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors |
| US7906533B2 (en) | 2004-11-03 | 2011-03-15 | Bayer Schering Pharma Ag | Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors |
-
1974
- 1974-05-24 JP JP5798574A patent/JPS5744672B2/ja not_active Expired
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000027819A3 (de) * | 1998-11-10 | 2000-08-17 | Schering Ag | Anthranilsäureamide und deren verwendung als arzneimittel |
| US7122547B1 (en) | 1998-11-10 | 2006-10-17 | Schering Ag | Anthranilic acid amides and the use thereof as medicaments |
| US7615565B2 (en) | 2002-07-31 | 2009-11-10 | Bayer Schering Pharma Aktiengesellschaft | VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines |
| US7572794B2 (en) | 2004-11-03 | 2009-08-11 | Bayer Schering Pharma Ag | Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors |
| US7902229B2 (en) | 2004-11-03 | 2011-03-08 | Bayer Schering Pharma Ag | Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors |
| US7906533B2 (en) | 2004-11-03 | 2011-03-15 | Bayer Schering Pharma Ag | Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5744672B2 (US07122547-20061017-C00002.png) | 1982-09-22 |
